Indigenous Bloom Hemp Corp. (VRTHF)

[TPX]

Veritas Pharma Announces Loan to Marapharm and Cancellation of Stock Options

by Sam Eskandari | Jul 27, 2018 | News

VANCOUVER, British Columbia, July 27, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that effective June 25, 2018, it cancelled a total of 3,272,000 incentive stock options (“Options”)...
Veritas Pharma Signs IP Agreement with UK’s First Medicinal Cannabis Investment Fund
by Sam Eskandari | Jul 17, 2018 | News

VANCOUVER, British Columbia, July 17, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that it has signed an Intellectual Property Sharing Agreement (“Joint IP”) with Sativa Investments PLC...
Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries
by Sam Eskandari | Jun 26, 2018 | News

VANCOUVER, British Columbia, June 25, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Mr. Filios Theodorou has been appointed as its business development agent in Cyprus. He will report...
Veritas Pharma Signs R&D and Medical Cannabis Supply Agreement with Colombian Producer Foliumed S.A.S.
by Sam Eskandari | Jun 19, 2018 | News

June 18, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with Colombian medical cannabis company Foliumed S.A.S...
Veritas Pharma Provides Corporate Update on Q2 2018
by Sam Eskandari | May 31, 2018 | News

VANCOUVER, British Columbia, May 31, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide a corporate update on its achievements, related scientific activities and growth strategies for the second...
Veritas Pharma Has Retained Cannabis Branding Firm for Design of Label and Packaging
by Sam Eskandari | May 15, 2018 | News

VANCOUVER, British Columbia, May 15, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce with the dealer licence being granted which was previously announced on December 28, 2017, the Company has...
Veritas Pharma Provides Comment on Canadian Senate Recommendation for a One-Year Deferment Legalizing Cannabis
by Sam Eskandari | May 10, 2018 | News

VANCOUVER, British Columbia, May 10, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) provides the following statement to the recommendation issued by Members of the Standing Senate Committee on Aboriginal Peoples...
Veritas Pharma Establishes New Subsidiary in Puerto Rico, USA
by Sam Eskandari | May 7, 2018 | News

May 4, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) is pleased to announce the establishment of new subsidiary Veritas Pharma Puerto Rico LLC (“Veritas PR”) in the US territory. With the...
Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board
by Sam Eskandari | Apr 19, 2018 | News

VANCOUVER, British Columbia, April 18, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K. Pugsley PhD, FBPhS, DSP, a consultant in safety pharmacology, has joined its advisory...
Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.
by Sam Eskandari | Apr 16, 2018 | News

3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is...

http://veritaspharmainc.com/news/